Study of VTD in Waldenstrom's Macroglobulinemia

NCT03335098 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Waldenstrom Macroglobulinemia
Lymphoplasmacytic Lymphoma

Interventions

DRUG: Bortezomib

Sponsor

Seoul National University Hospital

Collaborators

[object Object]